Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
William Welbourn
Observed name:
W. Welbourn
Observed institutions:
Intermountain Healthcare,
Duke University,
Duke Medical Center,
Durham VA Medical Center,
Myriad Genetics
OpenAlex ID:
A5024882980
Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with Prostatectomy
2014
·
Jay T. Bishoff
, Stephen J. Freedland
, et al.
·
The Journal of Urology
·
191
Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
2013
·
Stephen J. Freedland
, Leah Gerber
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
183
PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer
2014
·
Prabhakar Mithal
, Emma Allott
, et al.
·
International Journal of Urology
·
98
Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer
2013
·
Neal Shore
, Raoul Concepcion
, et al.
·
Current Medical Research and Opinion
·
53
PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival
2013
·
Chloe E. Atreya
, Zaina Sangale
, et al.
·
Cancer Medicine
·
52
PDF
Use of the cell cycle progression (CCP) score for predicting systemic disease and response to radiation of biochemical recurrence
2016
·
Michael O. Koch
, Jane S. Cho
, et al.
·
Cancer Biomarkers
·
19
PDF
Mp79-15 Prognostic Utility of the Cell Cycle Progression (ccp) Score Generated From Needle Biopsy in Men Treated With Prostatectomy
2014
·
Jay Bishoff
, Stephen Freedland
, et al.
·
The Journal of Urology
·
2
1475 Evidence for a Cell Cycle Proliferation “field Effect” in Prostate Cancer
2013
·
Filipe Carvalho
, William Welbourn
, et al.
·
The Journal of Urology
·
2
Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy.
2014
·
Jay T. Bishoff
, Stephen J. Freedland
, et al.
·
Journal of Clinical Oncology
·
1
Cell Cycle Progression (CCP) Score Significantly Predicts PSA Failure After EBRT
2013
·
J.K. Salama
, S. Freedland
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Abstract 1201: PTEN null expression is concordant in colorectal cancer primaries and metastases and associates with poor survival.
2013
·
Chloe E. Atreya
, Zaina Sangale
, et al.
·
Cancer Research
·
1
2242 Prognostic Utility of Ccp Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy
2013
·
Stephen Freedland
, Leah Gerber
, et al.
·
The Journal of Urology
·
1
Comparison of cell cycle progression (CCP) score to two IHC markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy
2018
·
P. Leon Bertrand
, G. Cancel Tassin
, et al.
·
European Urology Supplements
344 Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy
2014
·
J.T. Bishoff
, S.J. Freedland
, et al.
·
European Urology Supplements
Évaluation du score CCP (Prolaris® test), et de l’expression du gène PTEN, comme marqueurs prédictifs de la récidive après prostatectomie radicale
2013
·
G. Fromont
, J. Varinot
, et al.
·
The French Journal of Urology
719 Evidence for a cell cycle proliferation “field effect” in prostate cancer
2013
·
F. Carvalho
, W. Welbourn
, et al.
·
European Urology Supplements
Prognostic utility of CCP score in men with prostate cancer after primary external beam radiation therapy.
2013
·
Stephen J. Freedland
, Leah Gerber
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
18
Citation count:
604
H-index:
6
I10-index:
6
Year
Topic
Type